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Plasmodium falciparum CRK4 directs continuous
rounds of DNA replication during schizogony
Markus Ganter1†, Jonathan M. Goldberg1, Jeffrey D. Dvorin1,2†, Joao A. Paulo3, Jonas G. King4†,
Abhai K. Tripathi4, Aditya S. Paul1, Jing Yang1, Isabelle Coppens4, Rays H. Y. Jiang1†,
Brendan Elsworth1, David A. Baker5, Rhoel R. Dinglasan4†, Steven P. Gygi3 and Manoj T. Duraisingh1*
Plasmodium parasites, the causative agents of malaria, have
evolved a unique cell division cycle in the clinically relevant
asexual blood stage of infection1. DNA replication commences
approximately halfway through the intracellular development
following invasion and parasite growth. The schizont stage is
associated with multiple rounds of DNA replication and
nuclear division without cytokinesis, resulting in a multi-
nucleated cell. Nuclei divide asynchronously through schizogony,
with only the ﬁnal round of DNA replication and segregation
being synchronous and coordinated with daughter cell assem-
bly2,3. However, the control mechanisms for this divergent
mode of replication are unknown. Here, we show that the
Plasmodium-speciﬁc kinase PfCRK4 is a key cell-cycle regulator
that orchestrates multiple rounds of DNA replication throughout
schizogony in Plasmodium falciparum. PfCRK4 depletion led to a
complete block in nuclear division and profoundly inhibited DNA
replication. Quantitative phosphoproteomic proﬁling identiﬁed a
set of PfCRK4-regulated phosphoproteins with greatest func-
tional similarity to CDK2 substrates, particularly proteins
involved in the origin of replication ﬁring. PfCRK4 was required
for initial and subsequent rounds of DNA replication during schi-
zogony and, in addition, was essential for development in the
mosquito vector. Our results identiﬁed an essential S-phase
promoting factor of the unconventional P. falciparum cell
cycle. PfCRK4 is required for both a prolonged period of the
intraerythrocytic stage of Plasmodium infection, as well as
for transmission, revealing a broad window for PfCRK4-
targeted chemotherapeutics.
Malaria parasites proliferate through schizogony in the blood
stage of infection. A series of rapid rounds of DNA replication
and nuclear division produces a syncytial cell with approximately
20 nuclei. In contrast to the synchronous nuclear division observed
in other multinucleated cells, such as the early Drosophila embryo4,
Plasmodium falciparum nuclei divide asynchronously during the
blood stage, despite sharing the same cytoplasm2,3, suggesting that
cell-cycle progression is not governed by diffusible cytoplasmic
factors. Knockout screens have identiﬁed non-essential blood-
stage Plasmodium kinases and suggested those that could be essen-
tial for the regulation of schizogony5,6. The molecular mechanisms
regulating this diverged mode of replication are largely unknown,
yet the recent development of conditional gene expression technol-
ogies now allows the unequivocal demonstration of gene essentiality
in P. falciparum7–9.
To directly identify critical regulators of schizogony and simul-
taneously determine protein function, we adopted the destabiliza-
tion domain (DD) conditional knockdown approach7,10,11. We
generated endogenous DD fusions of 23 schizont-stage kinases in
the P. falciparum D10 strain and screened for vulnerability to desta-
bilization by DD (Fig. 1a,b and Supplementary Fig. 1a). Using this
approach, we found that two kinases, the cGMP-dependent protein
kinase (PfPKG) and the cdc2-related protein kinase 4 (PfCRK4),
had profound proliferation defects in the absence of Shield-1 and
showed dose dependency (Fig. 1c and Supplementary Fig. 1b,c).
Chemical inhibition of PfPKG has previously established its
essential role in parasite egress from erythrocytes at the end of
schizogony12,13, now conﬁrmed by conditional destabilization.
As previously observed14,15, we found little correlation between
the level of protein knockdown and the ability to reveal the essenti-
ality of other kinases previously thought to be essential6 using the
DD approach (Fig. 1d and Supplementary Figs 1d and 9). This
could be due to insufﬁcient destabilization of these proteins or
because they are required at different levels for asexual proliferation.
The biological function of PfCRK4 is unknown, and we con-
ﬁrmed its essentiality in a different parental line—P. falciparum
P2G12 (ref. 16)—which also produces gametocytes (Supplementary
Fig. 2). PfCRK4 is a member of an Apicomplexa-speciﬁc kinase sub-
family related to cyclin-dependent kinases (CDK) (Supplementary
Fig. 3 and Supplementary Data 1)17,18. In many organisms, CDKs
in complex with cyclins regulate key steps of the cell cycle and
other cellular functions19,20. Compared to human CDK2, the
kinase domain of PfCRK4 possesses multiple sequence inserts of
unknown function (Fig. 2a and Supplementary Fig. 4).
PfCRK4 is localized to the nucleus of late trophozoites and
schizonts, with the signal greatly diminished in segmented schizonts
that have undergone cytokinesis (Fig. 2b). Following conditional
depletion of PfCRK4 (Fig. 1d), parasites arrested at the
trophozoite-to-schizont transition (Fig. 2c). At ≥40 h post invasion
(h.p.i.), parasites [+] Shield-1 (that is, wild-type PfCRK4 levels)
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segmented into daughter cells containing nuclei and rhoptries
(apical organelles required for merozoite invasion), which are
characteristic of mature schizonts (Fig. 2d, top). In contrast,
parasites cultured [–] Shield-1 (that is, PfCRK4 is depleted)
showed no nuclear division or apical organelle biogenesis (Fig. 2d
bottom and Supplementary Fig. 5a).
Analysis of nuclei stained with ﬂuorescent DNA-speciﬁc dyes
conﬁrmed that the nuclei did not divide and revealed a substantially
distorted nuclear morphology (Fig. 2e and Supplementary Fig. 5b).
Hemispindle structures were evident in PfCRK4-depleted cells
(Fig. 2f and Supplementary Fig. 5c,d); however, they were greatly
enlarged relative to spindles in wild-type parasites and might
account for the nuclear distortion. Concordantly, division of the
centriolar plaque3,21, the parasite’s microtubule organizing centre,
was diminished (Fig. 2g). To ascertain whether PfCRK4 affects
DNA replication, we quantiﬁed the parasite’s DNA content by
ﬂow cytometry22,23. In wild-type parasites, DNA replication com-
mences at 29–32 h.p.i. (that is, parasites with C-values >1 appear),
but we found DNA replication to be profoundly inhibited in
PfCRK4-depleted parasites (Fig. 2h). In contrast, the development
of the mitochondria and apicoplast organelles was unaffected fol-
lowing depletion of PfCRK4 (Supplementary Fig. 5e,f ). The
PfCRK4-dependent block was completely reversible up to 38 h.p.i.
by the addition of Shield-1. However, reversion at 48 h.p.i. led to
very poor recovery (Fig. 2i), identifying a window within which
PfCRK4 depletion is cytostatic before becoming cytotoxic.
To elucidate the processes regulated by PfCRK4, we assessed
changes in the phosphoproteome of PfCRK4-depleted parasites at
two timepoints (Fig. 3a): at 29 h.p.i., whenPfCRK4 is already expressed
at the onset ofDNA replication (Fig. 2b,h) and also at 37 h.p.i., where in
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Figure 1 | Conditional destabilization identiﬁed P. falciparum CRK4 as essential for asexual blood-stage development. a, Schematic of the P. falciparum
blood-stage cycle indicating peak transcript times of kinases targeted with a destabilization domain. Purple, approximate onset of DNA replication; blue,
approximate duration of schizogony. b, Single-crossover 3′ replacement strategy to fuse candidate kinases with a haemagglutinin (HA) and a destabilization
domain (DD) tag, which destabilizes kinases in the absence of Shield-1. Note that PKAc, ABCk2 and PF3D7_0420100 were refractory to HA-DD fusion.
TF, targeting fragment. c, Effect of conditional kinase destabilization on parasite growth over two cycles (±s.d.). PMR, parasite multiplication rate. d, Western
blots demonstrate conditional destabilization of PfCRK4 in two genetic backgrounds. The level of knockdown is indicated below. H3, histone H3.
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Figure 2 | Nuclear-localized PfCRK4 is essential for the trophozoite-to-schizont transition and DNA replication. a, Domain structure of PfCRK4. Blue, kinase
domain; yellow, kinase domain insertions relative to human CDK2; red, predicted nuclear localization signal (NLS); asterisk, active site residues; 1 and 1,553, ﬁrst
and last amino acid (AA), respectively. b, Immunoﬂuorescence detection of PfCRK4-HA-DD in blood-stage parasites (representative of three biological
replicates). DIC, differential interference contrast. Scale bar, 3 μm. c, Light microscopy of May–Grünwald–Giemsa-stained PfCRK4-depleted parasites (D10
parent, representative of two biological replicates and results with P2G12-PfCRK4-HA-DD). Scale bar, 2 μm. d, Ultrastructure of PfCRK4-depleted parasites (D10
parent, representative of n≥ 25 cells per condition). Arrowhead, spindle pole body; n, nucleus; Rh, rhoptry. Scale bars, 1 μm. e, Nuclear development in PfCRK4-
depleted parasites (D10 parent, representative of three biological replicates, and results with P2G12-PfCRK4-HA-DD). Scale bar, 2 μm. f, Immunoﬂuorescence
detection of spindle structures in PfCRK4-depleted parasites (P2G12 parent, representative of two biological replicates). Tub, tubulin. Scale bar, 2 μm.
g, Quantiﬁcation of centriolar plaques by immunoﬂuorescence in PfCRK4-depleted parasites (D10 parent; P value, chi-square test; representative of two
biological replicates and results with P2G12-PfCRK4-HA-DD). Cen, centrin. Scale bar, 1 μm. h, DNA content of PfCRK4-depleted parasites from both parental
lines; mean ± s.d. of technical triplicates (representative of three biological replicates); ring-stage DNA content deﬁned as 1 (C-value). i, Proliferation of
parasites when PfCRK4 was re-stabilized from 38 h.p.i. or 48 h.p.i. of the ﬁrst cycle onwards; mean ± s.d. (representative of two biological replicates and results
with P2G12-PfCRK4-HA-DD).
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Figure 3 | PfCRK4 regulates S phase. a, Schematic illustrating the sampling time points for phosphoproteomic proﬁling. b, Differential phosphorylation in D10-
PfCRK4-HA-DD parasites [–] Shield-1 relative to [+] Shield-1; 29 h.p.i. in duplicate, 37 h.p.i. in triplicate. P values, Student’s t-test. Grey-shaded regions indicate
>2-fold changes in phosphorylation and P <0.05. Numbers of peptides and respective proteins are indicated. c, GO term enrichment analysis of proteins with
≥2-fold-reduced phosphorylation (P <0.05). P values, modiﬁed Fisher’s exact test. Box shows P. falciparum homologues of S. cerevisiae factors required for origin
of replication activation in vitro with reduced phosphorylation at 37 h.p.i. in PfCRK4-depleted parasites. Pol, DNA polymerase; MCM, mini-chromosome maintenance
complex; TOP2, topoisomerase 2; RPA, replication protein A; ORC, origin recognition complex; eIF3, eukaryotic initiation factor 3. d, Percentage of shared GO
terms of proteins with ≥2-fold-reduced phosphorylation (P < 0.05) upon PfCRK4-depletion and of substrate sets of human and S. cerevisiae (Sc) kinases.
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wild-type parasites DNA replication is evident and when the PfCRK4-
dependent arrest is still reversible (Fig. 2h,i, Supplementary Fig. 6 and
Supplementary Data 2–5). Large changes occur in the phosphopro-
teome at 29 h.p.i., indicating that PfCRK4 is active when the ﬁrst
round of DNA replication commences (Fig. 2h). We used k-means
clustering to identify the phosphorylation sites most affected by
the PfCRK4 depletion, which showed a reduction of about 2-fold
(Supplementary Fig. 6b). Applying a threshold based on a ≥2-fold
decrease in phosphorylation and P values of <0.05, we identiﬁed
220 proteins (80 from 29 h.p.i. and 215 from 37 h.p.i., with 75 pro-
teins shared), suggesting that these belong to a PfCRK4-regulated
set of phosphoproteins (Fig. 3b and Supplementary Data 4).
Western blot analysis conﬁrmed differential phosphorylation of
histone H3 (serine 28) in a different genetic background
(Supplementary Fig. 6c). The most enriched phosphorylation
motif within these proteins was a previously undescribed SΦxK
motif (Φ, hydrophobic; x, any amino acid), with S being phosphory-
lated. The canonical CDK motif S/TP (refs 24,25), with S or T phos-
phorylated, was also enriched (Supplementary Fig. 6d,e).
To examine the functional signiﬁcance of the PfCRK4-regulated
set of proteins, we used gene ontology (GO) term enrichment analysis
(Fig. 3c). The most enriched biological-process GO term was ‘DNA
replication’, and ‘nucleus’ was the most enriched cellular-component
GO term. Strikingly, six of the seven identiﬁable P. falciparum
homologues (or subunits thereof) of the 16 Saccharomyces cerevisiae
factors required for origin licensing and ﬁring in vitro26 showed
reduced phosphorylation in PfCRK4-depleted parasites (Fig. 3c
box, Supplementary Fig. 6f and Supplementary Data 3 and 4).
GO terms of proteins with a ≥2-fold increase in phosphorylation
(P < 0 .05) were enriched for biosynthetic and intracellular transport
processes at 37 h.p.i., perhaps indicating secondary effects, but
no statistically signiﬁcant enrichment was observed at 29 h.p.i.
(Supplementary Fig. 6g).
We next compared the GO terms of the PfCRK4-regulated set with
GO terms of other available kinase substrate sets—one S. cerevisiae
kinase27 and 19 human kinases28 (www.phosphosite.org)—each with
≥30 conﬁrmed substrates (Fig. 3d). The substrate set of human
CDK2, a major S-phase promoting factor, showed the highest percen-
tage of shared annotations, suggesting that PfCRK4 acts in a related
fashion to promote the S phase in P. falciparum.
PfCRK4 protein levels increased through early and mid schizogony
(Fig. 2b) and its transcripts peak the latest of all putative Plasmodium
CDK-like kinases29. We therefore hypothesized that PfCRK4 is crucial
for all rounds of DNA replication seen in schizogony. When we
depleted PfCRK4 at points later in schizogony, we detected no further
increase in DNA content (Fig. 4a), premature termination of nuclear
division (Fig. 4b), and the parasites failed to proliferate (Fig. 4c), thus
demonstrating that PfCRK4 function is critical throughout schizogony.
To determine a role for PfCRK4 in other life-cycle stages, we used
the P2G12-PfCRK4-HA-DD line that produces high levels of gameto-
cytes to analyse PfCRK4 function during parasite transmission to the
Anopheles gambiae mosquito vector. Although we detected nuclear
expression of PfCRK4 in gametocytes (Fig. 4d and Supplementary
Fig. 7a), depletion during the latter portion of gametocyte develop-
ment (that is, from day 6 to day 16 post-induction) had no effect on
gametocytaemia nor on the male-to-female gametocyte ratio
(Supplementary Table 1). PfCRK4 depletion also did not impair exﬂa-
gellation (Supplementary Fig. 7b–d). We observed a reduced PfCRK4
signal in ookinetes (Supplementary Fig. 7e), and the numbers of
oocysts onAn. gambiae femalemidgutswas greatly diminished follow-
ing PfCRK4 depletion (Fig. 4e and Supplementary Fig. 8). Oocysts
derived from gametocyte cultures in the presence of PfCRK4
showed multiple nuclei, well-expanded organelles and a well-devel-
oped capsule (Fig. 4f, top). In contrast, infections with PfCRK4-
depleted gametocytes resulted in necrotic parasites reminiscent of
dead ookinetes, the motile zygote of Plasmodium parasites (Fig. 4f
bottom and Supplementary Fig. 8). This indicates that PfCRK4 is
required at some point during ookinete formation and early oocyst
development, andmight playa role duringDNAreplication in zygotes.
Our data provide evidence that PfCRK4 is an essential protein
kinase promoting S phase through the initiation of multiple
rounds of DNA replication during schizogony. Phosphorylation is
probably important for the regulation of PfCRK4 (Supplementary
Figs 3b and 4a), but a potential cyclin dependence is in question,
as the cyclin-binding domain is poorly conserved (Supplementary
Fig. 4a)17. Interestingly, homologues of Group I cyclins are not
found in the Plasmodium genome, including cyclin E, which is criti-
cal for the G1/S transition in other organisms30. Interventions tar-
geting PfCRK4 function would be efﬁcacious throughout the
extended period of schizogony in the clinically relevant blood
stage, as well as in the transmission stages, which taken together
are attractive features for future drug development.
Methods
Reagents and oligonucleotide primers.Wepurchased chemicals from Sigma-Aldrich
(unless otherwise noted), primers from Integrated DNATechnologies (sequences are
available upon request) and restriction enzymes from New England Biolabs.
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Construction of plasmids. The terminal 1–2 kb of PKB (PF3D7_1246900), TLK4
(PF3D7_0623800) and PKG (PF3D7_1436600) were subcloned into the 3′
replacement vector pJDD41 (ref. 7), generating HA-DD single-crossover tagging
plasmids. The terminal ∼1 kb of PF3D7_0420100 was ampliﬁed using an extended
reverse primer, introducing two additional HA-tags. Cloning into pJDD41 resulted
in a 3xHA-DD single-crossover tagging plasmid. All other targeting fragments were
subcloned into this 3xHA-DD plasmid (sequences available upon request).
Parasite culture, transfection and synchronization. P. falciparum D10 was
obtained from the Walter and Eliza Hall Institute (Melbourne, Australia).
P. falciparum P2G12 (clone of 3D7) was obtained from Harvard T.H. Chan School
of Public Health (Boston, USA). Parasites were cultured as previously described in
RPMI 1640 medium supplemented with 0.5% Albumax-II (Invitrogen), 50 mg l−1
hypoxanthine, 0.21% sodium bicarbonate and 25 mM HEPES (EMD Biosciences)31.
Human O+ erythrocytes (Research Blood Components) were diluted to 2–4%
haematocrit. Transgenic parasites were generated by electroporation of synchronized
ring-stage parasites as previously described32. Single homologous recombination
events were selected in the presence of 500 nM Shield-1 by cycling WR99210
(Jacobus Pharmaceutical Company) on and off, and cloned by limiting dilution.
Parasites were synchronized by a combination of heparin and sorbitol treatments as
previously described33. Unless otherwise noted, DD-tagged parasites were cultured
in 250 nM Shield-1. When desired, Shield-1 was removed by triple washes with
excess RPMI.
Southern blot analysis. Genomic DNA was collected with a QIAamp Blood Mini
Kit (Qiagen) and digested with the enzymes indicated in Supplementary Fig. 1a,
resolved on 0.8% agarose gels, transferred to GeneScreen Plus (Perkin Elmer) and
hybridized with speciﬁc radiolabelled probes.
May–Grünwald–Giemsa staining and imaging of blood-stage parasites. Air-dried
thin-smear blood ﬁlms were ﬁxed and stained according to manufacturers’
instructions and imaged on a Zeiss AxioCam microscope equipped with a ×100
oil-immersion objective. Raw images were analysed using ImageJ (ref. 34).
Dose response experiments. Dose response curves were generated as previously
described using SYBR Green I (ref. 35). In brief, triplicate twofold Shield-1 dilution
series were set up in 100 µl parasite cultures (0.075% parasitaemia in 2%
haematocrit). After two cycles, parasites were lysed with 20 µl of 6× SYBR green I
lysis buffer (0.16% saponin; 20 mM Tris-HCl, 5 mM EDTA, 1.6% Triton X-100,
pH 7.4), supplemented with 1:1,000 SYBR green I (from 10,000× stock, Thermo
Fisher). Fluorescence intensity was measured on a SpectraMax M5 plate reader
(Molecular Devices).
Conditional destabilization screen of schizont-stage kinases. We used the relative
log10 parasite multiplication rate (PMR) [–] over [+] Shield-1 as a measure of the
effect of conditional destabilization of schizont-stage kinases. Synchronized ring-
stage parasites of all P. falciparum kinase-DD fusion lines were seeded in triplicate at
0.05% parasitaemia, 0.5% haematocrit [+] or [–] Shield-1. Parasitaemia was
monitored by ﬂow cytometry (see below) and expressed as log10. Linear regression
analysis (Prism, GraphPad) allowed PMR to be calculated. The effect of protein
knockdown ([–] Shield-1) relative to [+] Shield-1 was plotted as log10 PMR [–]
Shield-1 over log10 PMR [+] Shield-1. The error (standard deviation, s.d.) for
f = A
B
where A is log10 PMR [–] Shield-1 and B is log10 PMR [+] Shield-1, was propagated
as
sf = f
∣∣ ∣∣
NameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMe
sA
A
( )2
+ sB
B
( )2√
where sA and sB are the sample standard deviations in A and B, respectively
36.
Parasitaemia quantiﬁcation by ﬂow cytometry. Parasitized erythrocytes were ﬁxed
as described previously37, stained with 1:2,000 SYBR green I (Life Technologies) in
PBS and analysed on a Miltenyi MACSQuant ﬂow cytometer. Data were analysed
using FlowJo (Tree Star) and Prism (GraphPad) software.
Immunoblot analysis. Synchronized parasites were collected and uninfected
erythrocytes were removed using 0.05% saponin in PBS plus 1× cOmplete protease
inhibitor cocktail (Roche). Following washes, parasites were lysed in Laemmli
sample buffer and proteins were resolved by SDS–PAGE, transferred to
nitrocellulose and probed with the following primary antibodies: anti-HA (1:1,000,
Roche, clone 3F10), anti-Pflactate dehydrogenase (LDH) (1:2,000, gift from M.T.
Makler), anti-histone H3 (1:1,000, Abcam, ab1791), anti-pS28 histone H3 (1:1,000,
Abcam, ab5169) anti-Pfaldolase (1:40,000, Abcam, ab38905). Signal intensities were
quantitated using ImageJ.
Gametocyte assays and An. gambiae infections. Gametocyte cultures were seeded
at 0.5% parasitaemia in 5 ml RPMI with 10% serum, 4% haematocrit and 1 µM
Shield-1 and kept in a candle jar at 37 °C. From day six onwards, parasites were
cultured [+] and [–] Shield-1. Estimates for the various stages and sexes were
determined from a Giemsa-stained thin-smear blood ﬁlm. On days 15 to 18 of
culture, parasites were collected and male gametocyte exﬂagellation was assessed by
microscopy. For the infection of An. gambiae KEELE strain females, cultures were
washed and gametocytaemia was adjusted to 0.3% in normal human serum with
45% haematocrit. Subsequently, females were infected in a standard membrane
feeding assay as previously described38.
Oocyst quantiﬁcation. Midguts from infected An. gambiae females were dissected
on days 7 or 8 post blood-feeding, and the number of oocysts were then enumerated
following 0.1% mercurochrome staining and analysis by light microscopy
(×20 objective).
DNA content analysis. The DNA content of parasites was determined by ﬂow
cytometry. Parasitized erythrocytes were ﬁxed in 4% paraformaldehyde and 0.0075%
glutaraldehyde for 45 min at room temperature37. To reduce the RNA-derived
background signal, cells were permeabilized with 0.1% Triton X-100, treated with
0.3 mg ml–1 RNase A for 20′ at 37 °C and subsequently washed. Cells were stained
with 1:2,000 SYBR green I (Life Technologies) in PBS, washed, and analysed on a
Miltenyi MACSQuant ﬂow cytometer. Data were analysed using FlowJo (Tree Star),
Excel (Microsoft) and Prism (GraphPad) software. Second-cycle ring-stage parasites
were omitted for DNA content analysis of 48 h.p.i. schizont-stage parasites.
Immunoﬂuorescence assays. Immunoﬂuorescence assays of blood-stage parasites
was carried out as previously described37,39. In brief, parasitized erythrocytes were
air-dried, methanol-ﬁxed39, and analysed using rat anti-HA (1:100, Roche, clone
3F10), mouse anti-centrin (1:500, Millipore, clone 20H5), mouse anti-α-tubulin
(1:2,000, Sigma-Aldrich, clone B-5-1-2), rabbit anti-PfGAP45 (1:2,000, gift from J.C.
Rayner) or rabbit anti-PfEBA175 (1:500, Malaria Research and Reference Reagent
Resource Center, R3347) antibodies. Alternatively, parasites were ﬁxed in solution37
for 20 min at room temperature, immobilized on poly-L-lysine coated coverslips
(Corning), and analysed using mouse anti-α-tubulin (1:2,000, Sigma-Aldrich, clone
B-5–1–2) or rabbit anti-PfACP40 (1:500, gift from S.T. Prigge) antibodies. Primary
antibodies were detected using Alexa Fluor-conjugated secondary antibodies
(1:2,000, Thermo Fisher Scientiﬁc). Cells were mounted with DAPI (4′,6-diamidino-
2-phenylindole) Fluoromount-G (SouthernBiotech) or cells were stained with
Hoechst 33342 (Thermo Fisher Scientiﬁc) and mounted with Fluoromount-G
(SouthernBiotech), imaged on a Nikon Eclipse TE300 microscope equipped with a
Hamamatsu C10600 Orca R2 digital camera, and analysed using ImageJ software.
For immunoﬂuorescence analysis of exﬂagellation, mature gametocytes were
resuspended in RPMI 1640 medium supplemented with 20% human serum (AB+),
50 mg l–1 hypoxanthine, 0.21% sodium bicarbonate, 25 mM HEPES (EMD
Biosciences) and 50 µM xanthurenic acid at room temperature and pH 8 to induce
exﬂagellation41. Following 20 min incubation at room temperature, cells were
washed, spotted on a glass slide, air-dried, methanol-ﬁxed and processed further as
described above.
For immunoﬂuorescence analysis of ookinetes, female An. gambiae mosquitoes
were fed with late-stage PfCRK4-HA-DD gametocyte cultures, which were
maintained [+] and [–] Shield-1 from day 6 post-induction. Approximately
24 h post-feeding, the blood bolus from the mosquito midgut lumen was isolated.
Bolus material was spotted on glass slides and air-dried before
immunoﬂuorescence analysis.
Immunoﬂuorescence analysis of P. falciparum late midgut oocysts was done as
previously described42. In brief, dissected midguts were ﬁxed in 4%
paraformaldehyde for 1 h at room temperature, washed, permeabilized and blocked
using 0.2% Triton X-100 in 1% bovine serum albumin in PBS. Midgut oocysts were
analysed using a mouse anti-circumsporozoite (CS) protein antibody (15 µg ml–1,
gift of P. Sinnis), an Alexa Fluor 594 secondary antibody (1:1,000) and DAPI nuclear
stain, mounted on a glass slide in 10% glycerol in PBS and imaged on a Nikon
Eclipse 90i microscope. Raw images were analysed using Volocity software
(Perkin–Elmer).
JC-1 staining of P. falciparum mitochondria. Parasite mitochondria were stained
with the cationic mitochondrial membrane potential sensor JC-1 (Life
Technologies) as previously described43. In brief, 2 µM JC-1 in 37 °C warm RPMI
was ﬁltered using an Acrodisc Syringe Filter (0.2 µmHT Tuffryn Membrane, Pall) to
removed preformed JC-1 aggregates. Parasites were incubated with JC-1-containing
medium for 20 min at 37 °C, washed, and imaged immediately on a Nikon Eclipse
TE300 microscope equipped with a Hamamatsu C10600 Orca R2 digital camera and
analysed using ImageJ software.
Electron microscopy. Synchronized blood-stage parasites were isolated by magnetic
afﬁnity puriﬁcation using a MACS LS column (Miltenyi Biotec), adjusted to ∼50%
parasitaemia with uninfected erythrocytes and resuspended in 200 µl 3% BSA in
PBS. Cells were ﬁxed for 1 h at room temperature with an equal volume of 2.5%
paraformaldehyde, 5.0% glutaraldehyde and 0.06% picric acid in 0.2 M cacodylate
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buffer. Cells were washed in cacodylate buffer, post-ﬁxed for 1 h with 1% osmium
tetroxide (OsO4), 1.5% potassium ferrocyanide (KFeCN6) and washed in H2O.
Following 1 h incubation in 1% aqueous uranyl acetate solution, samples were
washed in H2O and subsequently dehydrated in grades of alcohol. The samples were
placed in propyleneoxide for 1 h and inﬁltrated in a 1:1 mixture of propyleneoxide
and TAAB Epon (Marivac) over night. Samples were embedded in TAAB Epon and
polymerized at 60 °C for 48 h. Ultrathin sections from a Reichert Ultracut-S
microtome were mounted on copper grids and stained with lead citrate. Samples
were imaged on a Tecnai G2 Spirit BioTWIN with an AMT 2k charge-coupled
device camera under 80 kV.
For P. falciparum oocyst thin-section transmission electron microscopy, infected
midguts were ﬁxed at day 7 post-infection in 2.5% glutaraldehyde (Electron
Microscopy Sciences) and processed as described in ref. 44. Stained sections were
examined with a Philips CM120 electron microscope under 80 kV.
Phosphoproteomic proﬁling
Cell culture and collection. Synchronized D10-PfCRK4-HA-DD parasites were
cultured for 29 or 37 h.p.i. [+] or [–] Shield-1. At 29 h.p.i., duplicate samples were
collected, and at 37 h.p.i., triplicate sampleswere collected for both [+] and [–] Shield-1.
For each of the ten samples, ∼1.25 × 109 parasites were isolated, and uninfected
erythrocytes were removed using saponin buffer (0.05% saponin in PBS plus
1× PhosSTOP (Roche), 1× cOmplete protease inhibitor cocktail (Roche) and 1 mM
phenylmethanesulfonyl ﬂuoride (PMSF)). Subsequently, cells were washed in saponin
buffer to further remove erythrocytes and erythrocyte debris, followed by washes with
PBS plus 1× PhosSTOP, 1× cOmplete protease inhibitor cocktail and 1 mM PMSF.
Cell lysis and protein digestion. Lysates were prepared as previously described45,46. In
brief, cells were lysed in 8 M urea, 100 mM sodium chloride, 25 mM TRIS pH 8 plus
1× PhosSTOP, 1× cOmplete protease inhibitor cocktail and 1 mM PMSF in PBS.
The protein concentration was estimated in the Bio-Rad Protein Assay (Bio-Rad).
Disulﬁde bonds were reduced with 5 mM tris(2-chloroethyl) phosphate (TCEP) for
30 min at 37 °C. Cysteines were alkylated with 15 mM iodoacetamide for 30 min at
room temperature in the dark, followed by incubation with 5 mM dithiothreitol
(DTT) for 15 min at room temperature in the dark to quench excess iodoacetamide.
Chloroform-methanol precipitated proteins47 were resuspended in 8 M urea,
50 mM HEPES pH 8.5 and subsequently diluted to 1 M urea 50 mM HEPES pH 8.5
for digestion with LysC protease (1:100 protease-to-protein ratio, 3 h at 37 °C)
before the addition of trypsin (1:100 protease-to-protein ratio) and continued digest
overnight at 37 °C. The reaction was quenched with 1% formic acid, subjected to
C18 solid-phase extraction (Sep-Pak, Waters), followed by vacuum-centrifugation.
Isobaric labelling with tandem mass tags (TMTs). Peptides (200 µg) from each
sample were dissolved in 100 mM HEPES pH 8.5. Labelling with TMT reagents
(Thermo Fisher Scientiﬁc) was carried out according to the manufacturer’s
instructions and as previously described48. The TMT-labelled samples were
combined in a 1:1 ratio across all samples, vacuum centrifuged to near dryness, and
subjected to C18 solid-phase extraction (Sep-Pak, Waters).
Phosphopeptide enrichment. Peptides were resuspended in 100 mM HEPES pH 8.5
and phosphopeptides were enriched using Titanosphere TiO2 5 µm particles (GL
Biosciences) as previously described46,48,49. The ﬂow-through was kept for proteome
analysis. Enriched TMT-labelled phosphopeptides and peptides were dried by
vacuum centrifugation.
Ofﬂine basic pH reversed-phase (BPRP) fractionation. For protein level analysis, we
fractionated the pooled TMT-labelled peptide sample via BPRP high-performance
liquid chromatography as previously described48,50. Fractions were desalted, dried
and reconstituted in 5% acetonitrile, 5% formic acid for mass spectrometry
processing.
For phosphopeptide analysis, we used the Pierce Off-line BPRP fractionation kit
(Thermo Scientiﬁc). Fractions collected included organic buffer bumps with 5, 7.5,
10, 12.5, 15, 17.5, 20, 50 and 70% acetonitrile, in addition to the wash and ﬂow
through fractions. These fractions were vacuum-centrifuged to near dryness,
desalted via StageTip, dried and reconstituted in 5% acetonitrile/5% formic acid for
LC–MS/MS processing.
Liquid chromatography and tandem mass spectrometry. Data were collected using an
Orbitrap Fusion mass spectrometer (Thermo Fisher Scientiﬁc) coupled to a Proxeon
EASY-nLC II liquid chromatography (LC) pump (Thermo Fisher Scientiﬁc). Peptides
were fractionated on a 75 µm inner diameter microcapillary column packed with
∼0.5 cm Magic C4 resin (5 µm, 100 Å, Michrom Bioresources) followed by ∼35 cm
GP-18 resin (1.8 µm, 200 Å, Sepax). For each analysis, we loaded ∼1 µg onto
the column.
For total proteome analysis, peptides were separated using a 180 min gradient of
6–23% acetonitrile in 0.125% formic acid (ﬂow rate of ∼600 nl min–1). Each analysis
used the multi-notch MS3-based TMT method51. The scan sequence began with
an MS1 spectrum (Orbitrap analysis; resolution of 120,000, mass range of
400–1,400 m/z, automatic gain control (AGC) target of 2.0 × 105, maximum
injection time of 100 ms). Precursors for MS2/MS3 analysis were selected using a
TopSpeed 2 s method. MS2 analysis consisted of collision-induced dissociation
(quadrupole ion trap analysis: AGC of 4 × 103, normalized collision energy (NCE) of
35, maximum injection time of 150 ms). Following acquisition of each MS2
spectrum, we collected an MS3 spectrum using a recently described method in
which multiple MS2 fragment ions were captured in the MS3 precursor population
using isolation waveforms with multiple frequency notches51. MS3 precursors were
fragmented by high-energy collision-induced dissociation (HCD) and
analysed (NCE 55: AGC of 5 × 104, maximum injection time of 150 ms, resolution of
60,000 at 200 Th).
For phosphoproteome analysis, peptides were separated using a 120 min
gradient of 3–23% acetonitrile in 0.125% formic acid (ﬂow rate of ∼575 nl min–1).
Each analysis used the multi-notch MS3-based TMT method51. The scan sequence
was identical to the proteome scan, except the maximum injection time was 200 ms
for MS2 analysis and 250 ms for MS3 analysis.
Initial mass spectrometry data analysis. Mass spectra were processed using a
SEQUEST-based in-house software pipeline52. Spectra were converted to mzXML
using a modiﬁed version of ReAdW.exe. Database searching included all entries
from a combined Uniprot human and Plasmodium database (February 2015). This
database was concatenated with one composed of all protein sequences in the
reversed order. Total protein level analysis searches were performed using a 50 ppm
precursor ion tolerance, and product ion tolerance was set to 0.9 Da. These wide
mass tolerance windows were chosen to maximize sensitivity in conjunction with
SEQUEST searches and linear discriminant analysis52,53. TMT tags on lysine
residues and peptide N termini (+229.163 Da) and carbamidomethylation of
cysteine residues (+57.021 Da) were set as static modiﬁcations, while oxidation of
methionine residues (+15.995 Da) was set as a variable modiﬁcation for both total
proteome and phosphoproteome data sets. For phosphoprotein analysis, +79.966 Da
was set as a variable modiﬁcation on serine, threonine and tyrosine residues.
Peptide-spectral matches (PSMs) were adjusted to a 1% false discovery rate
(FDR)54,55. PSM ﬁltering used a linear discriminant analysis as previously
described52, while considering the following parameters: XCorr, ΔCn, missed
cleavages, peptide length, charge state and precursor mass accuracy. For the
phosphorylation data set, site localization was evaluated via AScore53. For TMT-
based reporter ion quantitation, we extracted the summed signal-to-noise (S/N)
ratio for each TMT channel and found the closest matching centroid to the expected
mass of the TMT reporter ion.
The search space for each reporter ion was limited to a range of 0.003 Th to
prevent overlap between the isobaric reporter ions. For protein-level comparisons,
PSMs were identiﬁed, quantiﬁed, collapsed to a 1% peptide FDR, and further
collapsed to a ﬁnal protein-level FDR of 1%. Protein assembly was guided by
principles of parsimony to produce the smallest set of proteins necessary to account
for observed peptides.
Proteins were quantiﬁed by summing reporter ion counts across all matching
PSMs using in-house software, as previously described52. Poor-quality PSMs, MS3
spectra with >8 TMT reporter ion channels missing, MS3 spectra with TMT reporter
summed S/N ratio <100, or no MS3 spectra were excluded from quantitation51.
Protein quantitation values were exported for further analysis in Microsoft Excel or
SAS JMP. Each reporter ion channel was summed across all quantiﬁed proteins and
normalized assuming equal protein loading of all ten samples.
Evolutionary relationship of PfCRK4. Protein kinase amino acid sequences from
the cyclin-dependent kinase (CDK) families of apicomplexans and model organism
and non-CDK out-group kinases were chosen for comparison with PfCRK4
(Supplementary Data 1). Kinase domain sequences were trimmed, aligned using
MUSCLE56 and analysed using RAxML57.
Domain drawings of PfCRK4 and its orthologues in Plasmodium spp. Domain
boundaries were identiﬁed by searching sequences against Pfam58 using the
HMMER package59. Domains were illustrated using Protdraw (http://sourceforge.
net/projects/protdraw/).
Homology modelling of PfCRK4. The protein kinase domain of PfCRK4 was
modelled using the co-crystal structure of the human CDK2-cyclin A-substrate
peptide complex (1QMZ.pdb)25. We used this structure as a template to model
PfCRK4 in a potentially active form. The kinase domains of the target and query
sequences were aligned using MUSCLE56 followed by manual review and
adjustment. Homology models were made using MODELLER 9.15 (ref. 60).
Structural alignments were reviewed and adjusted using Chimera61.
Identiﬁcation of conditionally related clusters in proteomic and
phosphoproteomic data. The total sum S/N values of peptides collapsed into
proteins are given in Supplementary Data 3. For phosphopeptides values see
Supplementary Data 4. Contaminants and false positives were removed and values
for each channel were normalized by the column sum. Values were placed on a scale
of 0–1 by dividing by the maximum value for the protein or phosphopeptide. Scaling
was done for all channels at once and separately for experiments at 29 h.p.i. and
37 h.p.i. Phosphopeptides for a total sum S/N ≤100 were not included in clustering
analysis and the total sum S/N values were adjusted to reﬂect protein levels from the
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proteome analysis. K-means clustering62 was done using R (http://cran.r-project.org/)
with the Hartigan–Wong method using 1,000 starting conﬁgurations and 10,000
iterations. Clustering results, log2-fold changes, and –log10 P values (Student’s t-test)
are included in Supplementary Data 3 and 4.
Gene orthology relationships. Relationships between P. falciparum proteins and
S. cerevisiae orthologues for the box in Fig. 3f (Supplementary Data 3) were
investigated using a downloaded version of the OrthoMCL database, version 5
(ref. 63). A comprehensive orthology analysis is provided in Supplementary Data 6.
Functional annotation and enrichment analysis. The functional enrichment of sets
of proteins with phosphopeptides most reduced in knockdown experiments at 29 h.p.i.
and 37 h.p.i. was assessed using Ontologizer64. Gene association ﬁles containing
gene ontology (GO) terms for P. falciparum, S. cerevisiae andHomo sapienswere from
http://www.geneontology.org/gene-associations (ref. 65; downloaded 21 May 2015).
To generate comparative heatmaps of GO terms for both time points we selected the
most speciﬁc terms, that is, those without children, which we refer to as ‘tips’ for
convenience. Enrichment P values were included in the heatmap if they were present
at either time point, and P values for non-tip terms were included if the term was a tip
at the other time point. GO term annotations of the proteins detected in this study are
provided in Supplementary Data 3 and deﬁned in Supplementary Data 7.
Functional comparison of the PfCRK4-regulated set of phosphoproteins. The
functional similarity between PfCRK4 and other protein kinases was assessed by
comparing GO terms of the PfCRK4-regulated set with GO terms of reference kinase
substrate sets. Reference human kinase substrate sets were obtained from
PhosphoSitePlus (http://www.phosphosite.org/staticDownloads.do)28 on 4 May
2015, and the substrate set for S. cerevisiae (Sc) cdc28 came from ref. 27. Reference
kinases with fewer than 30 identiﬁed substrates were omitted from the analysis.
Functional enrichment was assessed as described above. To calculate the relatedness
of the substrate sets of kinases with PfCRK4, the number of terms in the intersect of
the set of signiﬁcantly enriched functions from the PfCRK4-regulated set and the
substrate set from the reference kinases was divided by the number of signiﬁcant
functional terms in the substrate set from the reference kinase.
Identiﬁcation and enrichment analysis of phosphorylation motifs. Alignments of
phosphopeptides with reduced abundance in the absence of Shield-1 were manually
inspected. The two motifs discernable in this set may be retrieved from tab-delimited
tables of triskaidekapeptides by the regular expressions66\t[A-Z]{6}[ST]
[IVLFMWA].[RKH] (the SϕxK motif; ϕ, hydrophobic amino acid; x, any amino
acid) and \t[A-Z]{6}[ST]P (the S/TP motif ). The set of phosphopeptides detected in
this study (Supplementary Data 4) was searched with these regular expressions, and
the percentage of peptides composed of these motifs was calculated.
Phosphopeptides containing SϕxK and S/TP motifs are listed in Supplementary
Data 4. Sequence logos were made from alignments of phosphopeptides containing
SϕxK and S/TP motifs from sets of phosphopeptides reduced in the absence of
Shield-1 using Weblogo (http://weblogo.berkeley.edu)67.
Data availability. The data supporting the results of this study are available within
the paper and its Supplementary Information and Supplementary Data. Sequences
of oligonucleotides and plasmids generated for this study are available from the
corresponding author upon request.
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